Promising results of concomitant KI and RT have recently been published for melanoma and head and neck squamous cell carcinoma (HNSCC) and different targets, e.g., the previously mentioned ATM, ATR, DNA-PK, and PARP1/2 [12, 15–17]. Here, PARP1 is linked to melanoma.